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 INTRODUCTION
Regional anaesthesia is the blocking of peripheral nerve conduction in a reversible way 
by using local anesthetic agents, thereby one region of the body is made insensitive  to pain and 
is devoid of reflex response to surgical stimuli. In this the CNS is spared, so that the patient is 
conscious, fully aware during the surgical procedure without recognizing pain.
Regional  anaesthesia has many advantages over general anaesthesia for surgeries on 
upper extremities particularly in emergency surgeries.
They are:
(i) Proven to be the safest anaesthesia for high risk patients who are in greater risk due 
to stress imposed by general anaesthesia
(ii) Only method of anaesthesia which prevents all afferent impulses from the site of 
surgery reaching the CNS. Hence the need of poly pharmacy  and its side effects are 
eliminated.
(iii) Along  with  complete  pain  relief  and  total  muscle  relaxation  it  produces 
vasodilatation , which improve blood circulation, and prevents tissue hypoxia.
(iv) Causes least disturbance to the normal physiology than any other type of anaesthesia.
(v) Postoperative  pain  relief  is  ensured  for  a  longer  duration  by  using  long  acting 
anaesthetic drug and for several days if continuous block using catheter technique is 
employed.
(vi) Many intra operative, postoperative complication of general anaesthesia are avoided.
(vii) It is cost effective and safe.
(viii) Avoids theatre pollution .
(ix) Safest technique for patients with full stomach.
The use of pneumatic tourniquet provides a bloodless field during upper  extremity surgeries. 
The tourniquet pain is a concern because of the technical difficulty to block individual nerves. 
Brachial plexus block by supraclavicular approach is the solution in such a situation. There are 
different approaches for blocking brachial plexus, the common approaches are 
(a) Supraclavicular approach
(b) Interscalene approach
(c) Axillary approach
Axillary approach has the lowest incidence of serious complication and can be performed with 
ease. Still there is limitation associated with axillary approach like,
• It is inadequate for operation on the arm and shoulder
• It is difficult to block the musculocutaneous nerve predictably with resultant sparing of 
the radial aspect of forearm and dorsum of hand.
• Tourniquet pain is not well tolerated 
• Also abducting the arm by 90° for giving the block may be painful and even dangerous 
in traumatic lesions of the upper extremities.
Hence the brachial plexus block by low scalene approach is the method of choice for  upper 
limb surgeries. In 1970 Alon Winne first demonstered interscalene approach of brachial block. 
William Steward Halsted first performed brachial plexus block in 1885. In 1911 Kulenkampff 
and Hirschel described the first  percutanceous brachial plexus block by supraclavicular and 
axillary routes respectively. 
Since then several techniques have been used to prolong the brachial plexus block.
 Continues infusion of local anaesthetic through catheters
 Addition of epinephrine and α2 agonist like clonidine. 
 Addition  of  opioids  are  being  used  as  adjuvant  to  local  anaesthetic  solution  e.g. 
Morphine, Buprenorphine and butorphanol.
Buprenorphine, a thebaine derivative of semi synthetic opioid compound acts both on mu-
opioids  receptor  and Kappa  receptors.  It  is  used  for  pain  relief  and  this  is  given  by  intra 
muscular, intra venous,  epidural and spinal routes and the dose in 0.3 to 0.6mg. It is many 
times  more  potent  than  morphine  and  it  has  side  effects  of  nausea,  vomiting,  respiratory 
depression etc.
 This study compares the effects of addition of Buprenorphine to local anaethetic 
solution with plain local anaesthetic solution for brachial plexus block,with regard to onset, 
time for total blockade, duration and quality of blockade.
AIM OF STUDY
The opioid receptors are found in the central nervous system. The presence of these 
receptors in the somatic and sympathetic  peripheral nerves has also been documented. In this 
study  an  alternate  is  made  to  compare  the  effects  of  addition  of  buprenorphine  to  0.3% 
bupivacaine versus 0.3% bupivacaine, and also to evaluate the action of buprenorphine on the 
peripheral nerve receptors in brachial plexus block.
So, this is the study to
 To compare the effects and actions of 0.3% bupivacaine and addition of 150μg 
buprenorphine to 0.3% bupivaccine in brachial plexus block by low interscalene 
approach.
 To compare the onset, time taken for total blockade, duration and intensity of motor 
and sensory blockade.
 To evaluate the action of opioid , buprenorphine on the peripheral nerves.
ANATOMY OF BRACHIAL PLEXUS
Successful regional anaesthesia of the upper extremity requires knowledge of brachial 
plexus anatomy from its origin, where the nerves emerge from the inter vertebral foramina, 
to its termination as peripheral nerves. A through understanding of the plexus throughout its 
formation and distribution is equally essential in order to master the various techniques of 
brachial plexus analgesia.
In the course from the intervertebral foramina to the arm, the fibres that constitute the plexus 
are grouped as roots, trunks, divisions, cords and terminal    branches which are formed 
through a complex process of combining, dividing, recombining and finally redividing.
The brachial plexus is formed by the union of the anterior primary rami of the 5th to 8th 
cervical nerves and the 1st thoracic nerve with occasional contributions from the 4th cervical 
(prefixed) above and 2nd thoracic nerve (Post fixed) below. These roots unite to form trunks, 
which lie in the neck above the clavicle. They pass through the fascial  space formed 
between the scalenes anterior and the scalene medius muscles accompanied by  the 
subclavian artery  to form a neurovascular bundle. This fascia continuous as the axillary 
sheath upto axilla and upper third of arm. Each trunk divides behind the clavicle, into 
anterior and posterior divisions, which unite in the axilla to form the cords. In the neck the 
plexus is broad above and converges to the first rib.
RELATION OF BRACHIAL PLEXUS
ANTERIOR RELATIONS
The skin, superficial fascia, platysma and supraclavicular branches of the cervical plexus, 
the deep fascia and external jugular vein. The clavicle and lower part of the scalenus anterior 
muscle are also anterior to the roots.
POSTERIOR RELATIONS
Scalenus medias and the long thoracic nerve.
INFERIOR RELATIONS 
Related to the first rib.
SUPERIOR RELATIONS 
Lies first above and then lateral to the subclavian artery.
SYMPATHETIC CONTRIBUTIONS TO THE PLEXUS
Close to their emergence, the 5th and the 6th cervical nerves each receive a grey ramus 
from the middle cervical sympathetic ganglion. The 7th and the 8th cervical nerve each 
receive a grey ramus from the inferior cervical ganglion.
The following is the summary of the formation of the brachial plexus at different 
levels and its major terminal branches.
TRUNKS
Upper trunk – formed by the anterior rami of C5 and C6
Middle trunk – formed by the anterior ramus of C7
Lower trunk – formed by the anterior ramus of C8 and T1
DIVISIONS
Above the Ist rib each trunk divides into anterior and posterior divisions.
CORDS 
(i) The Lateral cord by anterior divisions of upper and middle trunks (C5 – C7)
(ii) Medial cord – Anterior division by lower trunk (C8 – T1)
(iii) Posterior cord – Posterior divisions of all the three trunks (C5 – T1)
BRANCHES 
Branches are given off from
• Roots 
• Trunks 
• Cords
FROM ROOTS
• Nerve to Serratus anterior  (C5, C6, C7)
• Muscular branches to Longus Cervices (C5 – C8)
• Nerve to three scalene (C5 – C8)
• Nerve to Rhomboids (C5)
• A twig to phrenic nerve (C5)
FROM THE TRUNKS
• Supra Scapular nerve (C5 and C6)
• Nerve to Subclavius (C5 and C6)
FROM THE CORDS 
• From Lateral Cord 
(i) Lateral pectoral (C5 - C7)
(ii) Lateral root of the Median (C5 - C7)
(iii) Musculo Cutaneous (C5 - C7)
• From Medial Cord
(i) Medial root of median nerve (C8 - T1)
(ii) Medial Pectoral (C8 - T1)
(iii) Medial Cutaneous N.of forearm (C8 - T1)
(iv) Medial Cutaneous N.of arm (C8 - T1)
(v) Ulnar (C8 - T1)
• Posterior Cord 
(i) Upper  subscapular nerve (C5 – C6)
(ii) Lower subscapular nerve (C5 – C6)
(iii) Thoracodorsal (C6 – C8)
(iv) Radial (C5 - T1)
(v) Axillary (C5 – C8)
The anaesthesiologist must have familiarity with the perineural structures that surround and 
accompany the brachial plexus as it leaves the vertebral column in its course to the upper 
arm and it is as important as the knowledge of the formation and distribution of the neural 
plexus itself. Palpable muscular and vascular landmarks allow accurate location of the 
plexus percutaneously. An appreciation of the fascial relations is absolutely essential since 
this is the basis for all the perivascular techniques.
After leaving the intervertebral foramina, the anterior primary rami of the nerves destined to 
become the brachial plexus travel in the gutter formed by the anterior and posterior tubercles 
of the corresponding transverse processes of the cervical vertebrae. After leaving the 
transverse process, the roots of the plexus descend in front of the middle scalene muscle, 
which arise from the posterior tubercles of the transverse process of the lower six cervical 
vertebrae. The insertion of this muscle on the firs rib is separated from that of the anterior 
scalene muscle by the inferior trunk of the brachial plexus. The anterior scalene muscle 
arises from the anterior tubercles of the transverse process of the third, forth, fifth and sixth 
cervical vertebrae and inserts on the scalene tubercle of the first rib thus separating the 
subclavian artery from the subclavian vein.
The fascia covering both the scalene muscles is derived from the prevertebral fascia, which 
splits to invest these muscles, and then fuses again at their lateral margins to form an 
enclosed interscalene space. Therefore, as the roots leave the transverses processes they 
emerge between two wall of the fascia covering the anterior and middle scalene muscles. In 
their descent toward the first rib to form the trunks of the plexus the roots may be considered 
to be sandwiched between the anterior and medial scalene muscles, the fascia of which 
serves as a sheath of the plexus. As the trunks approach the first rib they are arranged (as 
their designations – superior, middle and inferior-imply) one above the other vertically.
As the trunks of the plexus cross the first rib they are joined by the subclavian artery which 
lies in a plane anterior to the trunks, so that the inferior trunk lies behind the artery in the 
subclavian groove with the middle and superior trunks above the level of the vessel. At this 
level the artery and trunks are moving laterally across the ribs and invaginate the scalene 
fascia to form the subclavian perivascular space which is continuous medially and superiorly 
with the interscalene space and inferiorly and laterally with the axillary perivascular space.
The important concept is that there is a continuous, fascial enclosed perineural and 
perivascular space extending from the cervical transverse processes to several centimeters 
beyond the axilla. This space has been divided into an axillary perivascualr space and an 
interscalene space. The existence of such a continuous perineural space  renders brachial 
plexus block simple. The space described may be entered at any level and the volume of the 
anesthetic injected at that level would determine the extent of anesthesia. Thus the technique 
to be used in any case should be determined on the basis of the surgical site, the required 
level of anesthesia, and the physical status and habitus of the patient.
The upper medial aspect of the arm is not anaesthetized by the brachial plexus block 
technique since this area in innervated by the intercostobrachial nerve (T2). This nerve can 
be blocked by subcutaneous infiltration across the axillary artery using 3-5ml of local 
anaesthetic, which provides anesthesia for surgery or tourniquet.
The brachial plexus can be blocked at the level of the roots, trunks, cords, or peripheral 
branches. The block at each level has a distinct distribution of anesthesia, advantages, 
disadvantages and complications.
CLINICAL PHARMACOLOGY
A brief review of the clinical pharmacology of drugs used in this study is dealt with 
here.
LOCAL ANAESTHETICS
Local Anaesthetics are chemical compounds, which are capable of reversibly inhibiting 
the propagation of impulses in nerve cells.
The local anaethetics have a similar basic structure, consisting of an aromatic head, an 
intermediate chain and an amine tail. They are classified into 
1. Amino esters : they have an ester link which connects aromatic portion and the amine.
2. Amino amides : they have an amide link which connects the aromatic portion and 
the amine. 
BUPIVACAINE
Synthesized by Bo Af Evenstam in 1957 of AB Bofor in Sweden.
First came into clinical use in 1963.
Bupivacaine is an anilide compound. Chemical name is 1 n butyl DL
Piperidine  carboxylic acid 2.6 dimethly anilide chloride.
Presentation
As a clear solution containing 0.25/0.5/0.75% Bupivacaine hydrochloride-the 0.25/0.5% 
solutions are combined with 1:200000 adrenaline. The heavy solution contains 80mg/ml of 
glucose (with a specific gravity of 1.026) called bupivacine (heavy)
Physicochemical Properties 
pKa = 8.1
Protein binding : 96%
Lipid solubility : 28
Pharmacokinetics
Absorption: The absorption of local anesthetics is related to 
1. The site of injection (intercostals > epidural > brachial plexus > subcutaneous)
2. The dose – a linear relationship exists between the total doses and the peak blood 
concentrations achieved
3. The presence of vasoconstrictors which delay absorption
The  addition  of  adrenaline  to  bupivacaine  does  not  influence  the  rate  of  systemic 
absorption as, 
a) The drug is highly lipid soluble and therefore uptake into fat is rapid
b) The drug has a direct vasoconstrictory effect
Routes of administration / doses
Bupivacaine may be administered topically in infiltration, intrathecally or epidurally. 
The therapeutic dose of bupivacaine is 2mg/kg (with or without adrenaline).
The drug acts within 10 to 20 minutes and has a duration of action of 5 to 16 hours.
Pharmacodynamics:
The possible pathways for metabolism of bupivacaine include aromatic hydroxylation, 
N-dealkylation, amide hydrolysis and conjugation. Only the N-dealkylated metabolite N-
desbutyl bupivacaine has been measured in the blood or urine.
Alpha 1 acid glycoprotein is the most important protein-binding site of bypivacaine. 5% 
of the does is excreted in the urine as pipcolyloxylidine 16% is excreted unchanged. Clearance 
is 0.47 L/min and the elimination half-life is about 210 minutes.
Side Effects:
Systemic toxicity:
Cardiovascular system
Bupivacaine is  markedly cardiotoxic.  It  binds  specifically  to  myocardial  proteins.  In 
toxic  concentrations  the  drug  decreases  the  peripheral  vascular  resistance  and  myocardial 
contractility producing hypotension and possible cardiovascular collapse. Cardio toxic plasma 
concentrations of Bupivacaine are 8 to 10 μg/ml.
Central Nervous System
The principal effect of bupivacaine is reversible neural blockade. This leads to a 
characteristically biphasic effect in the central nervous system. During accidental overdosage 
or direct vascular injections the clinical signs are numbness of tongue, lightheadedness, visual 
and auditory disturbances, muscular twitching and tremors. The signs may progress to 
generalized convulsions of the tonic-clonic nature. When plasma levels continue to rise, CNS 
excitation is rapidly superseded by depression. (Drowsiness, disorientation and coma)
The typical plasma concentration of bupivacaine associated with seizures is 4.5 to 5.5 
microgram/ml.
BUPRENORPHINE
Buprenorphine is a synthetic derivative of the alkaloid thebaine. Its main action is analgesia. It 
is used in the treatment of moderate to severe pain. It can be given through intramuscular in the 
dose of 0.3mg, intravenously 0.3mg, sublingually 0.2, 0.4mg and epidurally  0.3mg.
Mode of action: 
The drug acts as partial agonist at mu-receipts but dissociates slowly from the latter 
leading to prolonged analgesia. Buprenorphine appears also to have a high affinity for kappa 
opioid receptors 
Chemical structure 
Special features 
 This  drug is many times  potent than morphine
Half life –166 minutes
Slow onset of action, peak flow occurs at 3 hrs and duration of action is more than 
10hrs, elimination half life is 5 hours 
Volume distribution (VD) is 2.8 L/kg
Clearance – 20ml/kg/min
 “CEILING EFFECT”
The increasing dose of buprenorphine above 0.15 to 1.2mg do not produce                     
additional analgesic  effect in adults.
  Reversal with naloxone is limited because of high affinity to mu receptors and slow 
dissociation from the receptor sites. 
 Buprenorphine is not removed by hemodialysis 
 Effects 
CVS: Following administration of this drug the heart rate may decrease up to 25% and 
systolic blood pressure may fall by 10%
RS: The drug produces respiratory depression and an antitussive effect, similar to produced 
by the morphine.
CNS: It produces miosis
AS: It delays the gastric emptying time and has an emetic effect
GU: This drug has been shown to reduce the rate of urine output in animals 
Metabolic effects: It decreases the luteinising hormone and increases the release  of 
proteins
Toxicity and side effects: It is same as morphine. Drowsiness, dizziness, headache, 
dysphoria, nausea and vomiting may be produced. It appears to be less liable to produce 
dependence than pure mu-agonists  
Kinetics 
Absorption: The drug is absorbed orally; but undergoes a significant first pass metabolism 
and the sub lingual route is therefore preferred. The bio availability is 40-90% when 
administrated intramuscularly and 44 to 94% when administered sublingually.
Distribution: Only unchanged buprenorphine appears to reach the CNS. It is 96% protein 
bound 
Metabolism: Occurs in the liver by dealkylation in the subsequent conjugation to 
glucoronide – the polar conjugates then appears to be excreted in the bile and hydrolyzed by 
bacteria in the GI tract
Excretion: Occurs predominantly via the faeces as unchanged buprinorphine the reminder 
is excreted in the urine as conjugated  buprinorphine and dealkylated derivatives.
PHARMACOKINETICS OF LOCAL ANAESTHETICS 
IN BRACHIAL PLEXUS BLOCKADE
When a local anaesthetic is injected around a nerve trunk, it will soak the trunk in an 
advancing front. Transmission in fibres situated in the periphery of the trunk (mantle fibres) 
will be first blocked and those in the centre of the trunk(core fibres) last. Further, transmission 
in peripherally placed fibres will be blocked over a longer length of time compared to central 
fibres.  Thus  analgesia  will  appear  first  and  last  longest  in  the  territory  supplied  by  the 
peripheral fibres. If the pool of local anesthetics is small or if the injection was not accurate or 
too dilute, the fibres in the center of the trunk will escape blockade.
Theory of Winnie
The trunks are arranged so that the central fibres are the longest supplying the 
extremities of the limb while shorter fibres are arranged more peripherally as their area of 
supply is more proximal. Winnie groups the fibres into two the peripheral mantle fibres which 
contain  motor fibres and core fibres which are mainly inner sensory  peripheral  motor fibres 
supply the muscles of the forearm and the  central fibres carry sensation from the hand. Thus 
the onset of block in the limb is as follows.
Loss of motor power to the shoulder and upper arm
Loss of sensation on the upper arm
Loss of motor power of the forearm
Loss of sensation to the hand.
So the spread of block is from proximal to distal.
REVIEW OF LITERATURE
• Halsted (1885-1922) of New York in 1884, Matas of New orleans (1860-1957) and 
Crile (1864-1943) of Cleveland in 1897, injected the plexus under direct vision 
following exposure under local infiltration (Intra-neural block).
• In 1940 Patrick described the “Classical approach”
• In 1970 Dr.AlonWinne described interscalene approach
• In 1922, Labat used multiple needles technique to block the brachial plexus using the 
Chassaignac’s tubercle as the land mark.
• In 1911, Hirshel described the first percutaneous technique for blocking the brachial 
plexus by axillary approach and reported on its successful use in these patients.
• In 1926, Livingston described  a technique that is fore-runner of subclavian 
perivascular technique.
• Kulenkampff, assistant to Heinrich Braun, after experimenting on himself used the 
supraclavicular technique in 1912.
• In 1949, Bonica and Moore advocated the “1st rib Walkover” technique.
• In 1989 Viel E.J. et al used Buprenorphine in brachial plexus block for post-operative 
pain relief.
• 1964, Winnie described the subclavian perivascular technique for accurate localization 
of the plexus.
• In 1980 field H.L. and Emson P.C, identified multiple opiate receptor sites on primary 
afferent fibres.
• In 1995, Wajima Z et as used Butorphanol in brachial plexus infusion for post-
operative analgesia.
• In 1987, Majs K.S. et al produced local analgesia without anaesthesia using peripheral 
perineural morphine injection.
• Candido et al in their study noted the brachial plexus block with addition of 
buprenorphine to local anasthetic solution prolonged the duration of analgesia
MATERIAL AND METHODOLOGY
Forty adult patients of both sexes in the age group of 18 to 58 belonging to ASA I/II 
attending the Plastic&hand reconstructive surgery department at Stanley Medical College 
Hospital, Chennai-1 formed the material for the study. They were randomly  divided into 2 
groups I and II
Group I
20 patients received 30 ml of 0.3% bupivacaine plus 1ml of isotonic sodium chloride 
solution making the solution 0.3%.
Group II
20 patients received 18ml of 0.5% bupivacaine plus 1ml of 150 microgram of 
buprenorphine.
Patient selection
• Only ASA I & ASA II were included 
• Age group between 18 to 58 years
• Weight between 40 to 70kg
• Both emergency and elective procedure involving the upper limb were included
• Both in patients and outpatients were included.
Exclusion criteria 
• Patient refusal 
• Clinically significant coagulopathy bacterial, fungal infection the injection site 
• Pneumothorax,
• Known epileptic
Equipment  
Sterile tray
Towel,
2 Nos. of Sterile cups
2 Nos. of 20ml glass syringes.
Sterile gloves
Swabs 
Sponge holding forceps
Betadine solution 50 to 100ml
Appropriate needles 
1 no. 23G  3.75 cm long needle
22G  4cm long short beveled blunt needle
Drugs used 
0.5% sensorcaine 1 vial distilled water 2 vials 
Bupergesic 1 amp (Buprenorphine 0.3mg)
Intra post operative-monitors 
Pulse Oximeter -  continuous
NIBP                -  5 minutes interval
ECG              -    Lead  II continuous
Initially the base line parameters were recorded before administering the block.
(i.e.) pulse 
BP
SPO2 and 
ECG
Then the block was administered. All these parameters were monitored intra and  post 
operatively. They were monitored for 12hrs. Patients were carefully observed for the 
development of complication and  side effects  and treated if occurred.
Procedure 
The block was given in the OT (or) the preparation room where all the facilities to 
resuscitate available. All patients were enquired for any drug reaction
 Intravenous line was started for all the patients with 18G (green) intravenous catheters 
and monitor were connected to the patient 
 The patient has positioned on the table and proper illumination was done at the site of 
block
 For continuous neurological evaluation, no sedative drugs were administered pre-
operatively.
LOW INTERSCALENE   BLOCK
The interscalene approach to block brachial plexus was first described by Dr. Alon 
winne in 1970. In this study, the interscalene groove was identified at the lower level near 
the clavicle where the ant.scalene and medial scalene muscles converge.
POSITION 
• The patient was placed in supine position with head turned to the contralateral side
• The arm of patient were adducted with the hands pointing towards the knee
• A rolled towel is placed lengthwise between the shoulders along the spine to give the 
best exposure of the area.
LANDMARKS
• The anesthesiologist stood at the head end of the patient 
• The patient is asked to lift the head slightly to bring the clavicular head of the 
sternocleidomastoid muscle into prominence.
• The finger is placed lateral to the muscle and the patient is told to relax. Roll the index 
finger laterally across the belly of the sternocleido muscle until the interscalene groove 
in palpated. To appreciate the groove classically the patient was asked to inspire. 
• The finger is then moved inferiorly down the groove until the pulse of the subclavian 
artery is palpated between the scalene muscles.
The following were the certain anatomical marks / relations to find out the interscalene 
groove.
• The interscalene groove is approximately 1.5 to 2.5cm above the midpoint of the 
clavicle.
• The external jugular vein is just above (or) near the groove.
• Subclavian artery is just medical to the groove.
 After finding out the interscalene groove the skin is cleaned with betadine and white 
spirit a skin wheel is raised at this point with 2ml of lignocaine with 23G needle about 
2.3cm above the midpoint of the clavicle.
PROCEDURE 
After sterile preparation of the region the 22G, 4cm needle was inserted through the skin 
wheal and above the palpating finger immediately lateral to the subclavian artery.
 It was directed 45˚ dorsolaterally parallel to the scalene muscles and towards the elbow 
of the patient. There was a click once the sheath is pierced and entered
 The patient felt paraesthesia of the hand and fingers once the tip of the needle crossed 
the perineural sheath.
In this technique paresthesia was obtained before the first rib was contacted. If 
paraesthesia was not elicited then the needle was withdrawn and  redirected  once again.
Eliciting paraesthesia especially “Distal paresthesia” was sought as a confirmatory 
index of being close to the nerves. Once achieved the percentage of successful blockade was 
found to be higher almost 99%.
Then the needle was carefully held at the same position and the drugs were injected. 
Potential pit falls were patient movement and failure to hold the needle at the point of 
eliciting paresthesia.
The following precautions were taken during injection of anaesthetic drugs
(i) Before injection, aspiration was done to see any blood (inadvertent intravascular 
placement of needle) in the syringe,
(ii) If there was any shooting pain then the needle was slightly withdrawn (as the 
needle tip entered neural tissue)
(iii) Repeated aspirations were done after every 3-5ml of drugs injected. After injection 
the block was tested for both sensory (using pin prick) and motor using muscle 
contraction and compared with same stimulation or power in the contralateral arm.
Motor block was evaluated by thumb abduction (Radial nerve), thumb adduction 
(ulnarnerve), thumb opposition (Median nerve) and flexion of the elbow in supination and 
pronation of the forearm (musculocutaneous nerve).
 The Hollmen’s scale was used to assess both sensory any motor blockade.   
THE HOLLMEN ’S   SCALE
SENSORY BLOCKADE
1. O  Normal sensation of pin prick
2. + Pin prick felt as sharp pointed but weaker compared 
with the same are in the other upper extremity
3. ++ Pin prick recognized as touch with a blunt object
4. +++ No perception of pin prick
MOTOR BLOCKADE 
1. O Normal muscle function 
2. + Slight depression in muscle function as compared with 
the preanaesthetic power.
3. ++ Very weak muscular action persisting in muscle
4. +++ Complete block with absent muscular action
The nerves studied in the block were 
Sensory 
1. Lateral cutaneous nerve of arm
2. Medial cutaneous nerve of arm
3. Medial cutaneous nerve of forearm
4. Posterior cutaneous nerve of forearm
5. Lateral cutaneous nerve of forearm
6. Median nerve
7. Ulnar nerve
8. Radial nerve
Motor 
Median (N)
Ulnar  (N)
Radial (N)
Musculocutaneous nerve
Evaluation was carried out for every minute after completion of the injection and the 
time of onset was noted for both sensory and motor blockade.
Onset  of blockade both sensory and motor was defined as a minimum of grade 2 in 
Hollmen’s scale.
Blockade was considered as complete when sensory and motor scores were atleast 
grade 3 in Hollmen’s scale.
Once the blockade was complete the patient was wheeled into the theatre and surgery 
was allowed to proceed.
Duration  of the sensory blockade was considered as the time interval between the 
local anaesthetic administration and the to onset of pain in the anasthetic arm during the post 
operative period.
The duration of the motor blockade was considered as the time interval between the 
local anaesthetic administration and the recovery of the muscle power.
Separate never blocks or supplementation with IV sedation and analgesia were carried 
out for five cases of which the blockade was inadequate / not taken up.
MONITORING 
During this regional anaesthetic procedure, the systemic toxicity due to delayed 
absorption of local anaesthetic drugs and the narcotic buprenorphine was monitored for 
about an hour after surgery. Ventilation, oxygenation and the consequences of surgery such 
as tourniquet  pain  were also monitored.
 The vital signs PR/SPO2 were monitored continuously and RR / BP intermittently.
 The every 5 to 10 minutes till the procedure was over
 Data were expressed as mean  ± sd.
 ‘P’ value < 0.05 was considered significant.
OBSERVATIONS
This study was conducted in government Stanley Hospital in the department of plastic 
surgery and hand reconstrive surgery. Forty patients scheduled to undergo elective / 
emergency upper arm surgery were included in the study and were randomly divided into 
two groups of twenty each
Group I : Twenty patients received 30ml of 0.3% bupivacaine and 1ml 
of isotonic sodium chloride solution.
Group II : Twenty patients received 30ml of 0.3% bupivacaine and 1ml 
of  0.15mg of buprenorphine 
PHYSICAL CHARACTERISTICS
Both the group of patients was studied statistically with respect to age, sex and 
weight. The groups were also compared with respect to onset of blockade, time taken for 
total  blockade, total duration of blockade and the intensity of blockade.
DEMOGRAPHIC PROFILE
The distribution of age in the two groups are shown below
TABLE-1
AGE DISTRIBUTION
Age distribution Group I Group II
18-28 11 13
28-38 45 4
38-48 34 2
48-58 0 1
P value 0.5086 (not significant)
The distribution of weight in the two groups are shown below
TABLE-2
WEIGHT DISTRIBUTION
Weight in Kgs Group I Group II
30-40 1 0
40-50 7 6
50-60 6 10
60-70 6 4
P value 0.3019 (not significant)
The distribution of sex in the two groups are shown below
TABLE-3
SEX DISTRIBUTION
Sex Group I Group II
Male 16 17
Female 4 3
ONSET TIME FOR BLOCKADE (MINUTES)
S.No
Group I Group II
Sensory Motor Sensory Motor
1. 8 5 2 1
2. 10 6 4 3
3. 7 3 3 2
4. 7 5 5 4
5. 7 5 8 7
6. 6 4 5 3
7. 7 5 5 3
8. 5 3 4 2
9. 6 4 5 3
10. 5 3 4 2
11. 6 4 4 3
12. 7 5 6 3
13. 5 3 4 2
14. 6 4 3 2
15. 6 3 4 2
16. 7 4 4 2
17. 8 5 4 3
18. 7 3 4 3
19. 6 4 3 2
20. 7 3 4 3
Mean 6.65 4.05 4.25 2.75
P  value:
Sensory : <0.0001 (Significant)
Motor   : 0.0005 ( Significant)
TIME TAKEN FOR TOTAL BLOCKADE (MINUTES)
S.No
Group I Group II
Sensory Motor Sensory Motor
1. 28 24 20 17
2. 20 17 22 18
3. 19 17 26 22
4. 19 15 25 23
5. 25 22 42 35
6. 21 19 27 23
7. 23 22 22 18
8. 19 15 25 22
9. 22 16 22 19
10. 20 15 17 16
11. 21 16 20 17
12. 20 18 19 16
13. 18 15 19 17
14. 19 17 17 16
15. 21 18 16 15
16. 21 17 16 14
17. 19 16 22 20
18. 18 15 28 20
19. 19 16 21 18
20. 18 15 22 18
Mean 20.5 17.25 22.4 19.2
P  value:
Sensory : 0.187 (Not Significant)
Motor   : 0.1047 (Not significant)
TOTAL DURATION OF BLOCKADE (MINUTES)
S.No
Group I Group II
Sensory Motor Sensory Motor
1. 270 225 602 572
2. 370 325 825 735
3. 356 316 679 634
4. 310 275 720 685
5. 380 320 589 559
6. 345 300 520 475
7. 420 340 740 680
8. 319 304 680 620
9. 349 329 745 680
10. 310 290 564 504
11. 320 290 745 720
12. 340 320 695 675
13. 310 290 687 660
14. 320 294 673 627
15. 345 335 790 733
16. 310 290 653 560
17. 320 300 748 688
18. 330 310 800 770
19. 290 275 562 502
20. 310 290 595 565
Mean 331.2 300.9 680.6 632.2
P  value:
Sensory : <0.0001 (Significant)
Motor   : <0.0001 (Significant)
INTENSITY OF BLOCKADE
The intensity of blockade was graded using the Hollmen’s Scale. The sensory and motor 
blockade of both the groups were compared.
Grading Group I Group II
Sensory 
1 0 0
2 13 1
3 7 5
4 0 14
Motor
1 0 0
2 7 4
3 13 9
4 0 7
P  value:
Sensory : <0.0001 (Significant)
Motor   : 0.0165 ( Significant)
DISCUSSION
In this prospective, randomized study, 40 patients satisfying the selection criteria 
underwent brachial plexus block with or without addition of buprenorphine, onset, 
completion, duration and intensity of blockade were compared and statistically analyzed. 
Results show that addition of 150 micrograms of buprenorphine to local anaesthetic 
solution 0.3% bupivacine causes significant increase in duration and intensity of the sensory 
and motor blockade, shortens the onset of sensory and motor blockade and there was no 
difference in the time taken for total blockade.
In this discussion we attempt a comparison of findings drugs in our study to these 
already quoted in the literature.
Viel and colleagues postulated three possible mechanism of action of prolonged 
analgesia produced by peripheral administration of opioids.
1. The dorsal nerve root tissues contain μ (mu) receptor finding sites. The axonal flow 
(or) movement of opioid receptor and various macromolecule in the neurons had 
been demonstrated by young and colleagues and bi-directional axonal flow of these 
proteins was demonstrated by Laduron. Young and colleagues demonstrated that 
these moving receptors circulated endorphins and their ligands in addition to 
exogenous opioids. The existence of such receptors is the base for the hypothesis that 
opioids act directly on the peripheral nervous system.
2. These opioids may diffuse from brachial plexus sheath to extramural and 
subarachnoid spaces and then bind with opioid receptors in the dorsal horn. 
Dauggard, dahl and Christensen measured morphine concentration in spinal fluid 
after perineural injection of morphine around femoral nerve and found that the 
concentration was inadequate to produce analgesia by acting directly on the spinal 
cord.
3. The evidence of axonal flow or various macromolecules suggests possible centripetal 
axonal transport of opioid into the substantial gelatinous after perinural injection.
Low doses of  peripherally administrated opioids can produce anti-nociceptive 
effects mediated by peripheral opioid receptor in the inflamed tissue of rat. Stein 
and colleagues postulate that activation of these neuronal receptors causes 
attenuation of the excitability of the nociceptive input terminals or inhibition of 
release of excitatory transmitters or both.
ONSET OF BLOCK
Ortells polo et al., in their study of modified supraclasiscular perivasular technique 
recorded an onset time of 4.9 ± 0.2 minutes and the time for motor paralysis at 15.2 ± 6.9 
minutes.
Vonguises et al, in their study recorded onset time of 6.95 ± 3.07 minutes
Odoom et al recorded the onset time for motor weakness between 5 to 10 minutes.
All the above studies support our study, in which the onset time for both motor and 
sensory was around 3-5 minutes. There was  statistical significant in the onset of sensory 
and motor blockade.
The mean time of onset of block
Group I : 4.05 ± 0.94451 minutes for Motor and 6.65 minutes for sensory
Group II : 2.75 ± 1.20852 minutes for Motor and 4.25 minutes for sensory
There was statistically significant difference in the time taken for onset of block, 
between the two groups.
TIME TAKEN FOR TOTAL BLOCKADE
The mean time for total blockade,
17.05 ± 2.63329 minutes for motor and 20.5 minutes for sensory in Group I
19.2 ± 4.53756 minutes for motor and 22.4 minutes for sensory in Group II
There was no statistically significant difference in the time taken for total blockade 
between the two groups.
DURATION OF BLOCK
Vong vises et al in their study of parascline approach to brachial plexus block 
recorded average duration of anaesthesia of five hours.
Jean Marc Bernard et al recorded mean duration of action of 260 ± 27 minutes
 Dalens et al recorded motor blockade lasting around 6 hours
 Carlo D. Franco et al in their study of subclasion perivascular practical plexus blocks 
recorded duration of action lasting upto 6 hours.
 Kapral et al in their study recorded sensory blockade of 299 ± 84 minutes and motor 
blockade of 259 ± 76 minutes.
Candido et al in their study recorded thirty hours of post operative analgesia in brachial 
plexus block by adding buprenorphine.
In our study the mean total duration of sensory blockade in 331.2 ± 33.5443 minutes in 
Group I and 680.6 ± 86.2722 minutes in Group II.
The mean total duration of motor blockade in 300.9 ± 26.0139639 minutes in Group I 
and 632.2 ± 85.0669087 minutes in Group II
The duration of sensory and motor blockade was prolonged in Group II with a 
statistically significant P value <0.0001.
NTENSITY OF BLOCK
In our study the intensity of block significantly increased in sensory  and motor 
blockade.
Intensity of sensory block
In group I : 7 patients had sensory blockade of grade 3 and 13 patients 
had grade 2 blockade
13 patients has motor blockade of grade 3 and 7 patients has blockade of 
grade 2.
In Group II : 14 patients has sensory blockade of grade 4, 5 patients  has 
grading 3 and are patient of grade 2.
7 patients has motor blockade of grade 4, 9 patients had grading 3 and 4 
patients of grade 2.
The P value was <0.0165 for motor and <0.0001 for sensory blockade which is statistically 
significant.
Complications and side effects
There was two incidences of arterial puncture without formation of hematoma. Needle 
was again repositioned and drug administrated – Blocks were successful.
 There was no other incidence of pnumothorax, neurological deficit, phrenie nerve palsy 
or horner’s syndrome.
 There was incidences of nausea and vomiting in Group II patients.
 There was inadequate blockade in 4 patients in Group I and “ulnar sparing” in Group II. 
The Group I patients were converted to general anaesthsia and the Group II patient was 
given separate ulnar nerve block.
Heart rate, Bp, O2 saturation and respiration were monitored and were stable. No differences 
were noted among the groups.
SUMMARY
1. Onset time of sensory and motor blockade is shorter in Group II than control 
Group I
2. There was no difference in the time for total sensory and motor blockade in both 
the groups
3. These was significant increase in the duration of blockade in the Group II than 
Group I
4. There was significant increase in the intensity of sensory and motor blockade in 
the Group II than Group I.
5. There was no complication due to addition of 150 micrograms of buprenorphine 
to 0.3% bupivacaine 
CONCLUSION 
We conclude that in brachial plexus block by low interscalne approach, the 
addition of 150μg of buprenorphine with 0.3% bupivacaine provides intense, prolonged 
sensory and motor blockade without complication when it is compared to the block 
produced by plain 0.3% of bupivacaine solution alone.
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PROFORMA
Name : Age/Sex:   Wt: IP.No: Surgery:
ASA Status :    Premed :
Group I/II Conc.& Vol of Solution : Technique :
Onset time Complete Blockade
Sensory :
Blockade :
Motor :
0 5 10 15 20 30 60 120 180 240 300 360 420
Vitals : PR
BP
RR
SPO2
Sensory & Motor Score
Radial N S
M
Median N S
M
Ulnar N S
M
Musculocut N S
M
Sensory Score
Lateral Cut N of 
arm
Medial Cut N of 
arm
Medial Cut N of 
Forearm
Lateral Cut N of 
forearm
Duration of Blockade : Sensory Tourniquet position
Motor Tourniquet pain
Grading of Block
Complication: 
Paraesthesia / Neurological deficient Nausea / Vomiting 
LA Toxicity Vascular Puncture
Pneumothorax 
MASTER CHART
CONTROL -0.3% BUPIVACAINE Alone 
NAME IP NO SEX AGE WEIGHT ONSET M ONSET S COM M COM S DUR. M DUR. S INT.M INT.S COMMENTS
1 Madankumar 245039 M 18 35 5 8 24 28 225 270 2 2  
2 Devanathan 246673 M 60   6 10 17 20 325 370 3 3  
3 Suresh 247796 M 30 59 3 7 17 19 316 356 3 2  
4 Krishnan 247941 M 41 55 5 7 15 19 275 310 2 2  
5 Bappiz 246702 M 25 48 5 7 22 25 320 380 3 2 KET.30mg IV
6 Jeevanandam 248009 M 34 62 4 6 19 21 300 345 3 3  
7 Vairamani 227840 M 34 51 5 7 22 23 340 420 3 2  
8 Prakash 248523 M 24 46 3 5 15 19 304 319 3 3  
9 Jothi 248530 F 23 45 4 6 16 22 329 349 3 2  
10 Anbaesivan 248731 M 42 61 3 5 15 20 290 310 2 2  
11 Loganathan 249045 M 28 52 4 6 16 21 290 320 3 2  
12 Perumal 248082 M 34 64 5 7 18 20 320 340 3 3  
13 Ramesh 244057 M 18 45 3 5 15 18 290 310 2 2  
14 Subhashini 249152 F 18 48 4 6 17 19 294 320 2 2 CAMP2mg
             KET.30mg IV
15 Muniammal 249057 F 25 54 3 6 18 21 335 345 2 3 CAMP5mg
             KET.30mg IV
16 Ramu 249091 M 19 41 4 7 17 21 290 310 3 2  
17 Anilkumar 249095 M 48 64 5 8 16 19 300 320 3 3  
18 Jeyanthi 249019 F 25 48 3 7 15 18 310 330 2 2 CAMP5mg
             KET.30mg IV
19 Subramani 249150 M 40 64 4 6 16 19 275 290 3 3  
20 Manikandan 249168 M 24 53 3 7 15 18 290 310 3 2  
MEAN 30.5 52.368 4.05 6.65 17.25 20.5 300.9 331.2 2.65 2.35  
SD 11.20385 8.3879 0.94451 1.1821 2.6333 2.50263 26.013964 33.5443 0.489 0.489  
